Richard D. Truesdell, Jr.

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $2.75 billion aggregate principal amount of senior notes in four series, consisting of $300 million…

Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $200 million SEC-registered follow-on offering of 50,000,000 shares of common…

Davis Polk advised the representatives of the underwriters in connection with the $356.5 million initial public offering of 20,970,589 shares of common stock of WideOpenWest, Inc., which…

Davis Polk advised the sole book-running manager of a $359.35 million SEC-registered offering of 5,000,000 shares of common stock of Alnylam Pharmaceuticals, Inc. Alnylam’s common stock is…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of $200 million aggregate principal amount of Callon Petroleum Company’s…

Davis Polk advised the joint book-running managers on an SEC-registered offering of $400 million aggregate principal amount of 4.20% senior notes due 2047. Headquartered in Lake Forest,…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised Fogo de Chão, Inc. in connection with an SEC-registered secondary offering of 4,500,000 common shares by certain selling stockholders, for an aggregate price to the…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $150.4 million follow-on offering of 4,557,774 shares of common stock of…

Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300 million aggregate principal amount of its 3.25% convertible…